Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
12 March 2018 Photo Hanno Otto
Odeion School of Music opening concert presented on 17 March 2018
The Odeion School of Music Camerata 2018.
The University of the Free State’s Odeion School of Music is presenting the annual opening concert on Saturday, 17 March at 7:30pm at the Odeion. The programme will comprise a curated sequence of solo recitals, chamber music, including ensembles recited by the talented OSM students.

The Free State Youth Wind Ensemble will make their debut as part of the programme with an Ammerland recital by the Dutch composer Jacob den Haan (1959 -) as well as Majestia by James Swearingen (1947 -), an American born composer. This composition will be accompanied by a variety of diverse works.

George Foster and colleague Danré Strydom founded the ensemble in the form of a collaboration initiative between the Odeion School of Music and the Free State Symphony Orchestra. Six cellists, Chris van Zyl, Aschlin Grobbelaar, Marcus Motaung, Matthys Coetzee and John Minnaar will join forces with Prof Anmari van der Westhuizen to recite the riveting Requiem for Six Cellos and Piano, Op.66 by David Popper. 

During the concert, the OSM will bestow the Order of the OSM on string pedagogues Francois and Tilla Henkins, as a gesture of gratitude and respect for their lifelong dedication to the education and mentoring of several excellent South African violinists and cellists.

The OSM Camerata will end the concert with a rendition of the Romanian Folk Dances, Sz.56 Béla Bartok for Orchestra under the baton of Xavier Cloete. The OSM Camerata is the laureate of the first International Ictus Music Competition (University and Conservatory Orchestras) presented last year for the first time. For more information about the Odeion School of Music and the upcoming concert please visit the website.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept